Polyrizon Signs LOI to Develop Intranasal Psychedelic-Based Therapeutics

Polyrizon Ltd. (Nasdaq: PLRZ) (the “Company” or “Polyrizon”), a development stage biotech company specializing in the development...

March 14, 2025 | Friday | News
Axplora Expands ADC Manufacturing Leadership with New Payload Facility in France

Axplora, a global leader in API small molecule and ADC (antibody-drug conjugate) manufacturing, is strengthening its leading position in the commercial m...

March 04, 2025 | Tuesday | News
Callio Therapeutics Launches with $187M Series A for ADC Cancer Therapy

Callio Therapeutics, a biotechnology company focused on realizing the promise of multi-payload antibody-drug conjugates (ADCs) to improve cancer therapy, a...

March 04, 2025 | Tuesday | News
Amgen and AstraZeneca's TEZSPIRE® Demonstrates Significant Efficacy in Phase 3 WAYPOINT Trial for Chronic Rhinosinusitis with Nasal Polyps

Amgen and AstraZeneca announced full results from the Phase 3, registrational WAYPOINT trial demonstrating that TEZSPIRE® (tezepelumab-ekko) signi...

March 03, 2025 | Monday | News
Miltenyi Biotec Expands Global Footprint with New Cell & Gene Therapy Center in India’s Genome Valley

  Miltenyi Biotec, a global leader in cell and gene therapy solutions, has inaugurated a cutting-edge Cell & Gene Therapy Center in Genome Valley...

February 25, 2025 | Tuesday | News
Ilona Holcomb on How ImpriMed’s AI is Transforming Cancer Treatment for Pets and Humans

Artificial intelligence is reshaping oncology, and ImpriMed is at the forefront of this transformation. With its AI-powered Personalized Prediction Profi...

February 18, 2025 | Tuesday | Interview
Axplora Invests €50M in France’s Mourenx Site, Cementing Europe’s Leadership in Peptide Purification

The €50+ million investment will enhance Axplora CDMO’s Mourenx site with state-of-the-art facilities and infrastructure improvements. Axpl...

February 12, 2025 | Wednesday | News
M42 and Uzbekistan’s Ministry of Health Partner to Advance Genomic Research and Diversity

In a sign of its ambition to expand its foothold in genomics and grow its contribution to global genomics diversity, M42 and Uzbekistan’s Ministry ...

January 29, 2025 | Wednesday | News
Biogen's Higher Dose Regimen of Nusinersen for SMA Receives FDA and EMA Review

Biogen Inc. (Nasdaq: BIIB) announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s supplemental New Drug Applicati...

January 24, 2025 | Friday | News
Tanvex BioPharma Completes Acquisition of Bora Biologics, Launching Expanded Global CDMO Operations

Tanvex BioPharma, Inc.  (“Tanvex”), a contract development and manufacturing organization (CDMO) for biologics and a biosimilars product...

January 20, 2025 | Monday | News
Silexion Therapeutics Reveals Synergistic Efficacy of SIL-204 in Combination with Chemotherapy for Pancreatic Cancer

Silexion Therapeutics Corp. (NASDAQ: SLXN) (“Silexion” or the “Company”), a clinical-stage biotech developing RNA interference (RNA...

January 17, 2025 | Friday | News
Vertex Pharmaceuticals and Zai Lab Announce Exclusive Collaboration for Development and Commercialization of Povetacicept in Asia

-Vertex Pharmaceuticals Incorporated  and Zai Lab Limited announced an exclusive collaboration and license agreement for the development a...

January 13, 2025 | Monday | News
Zai Lab and MediLink Forge Global Partnership to Develop Groundbreaking LRRC15 ADC Therapy

Zai Lab Limited announced a new strategic collaboration and worldwide license agreement with MediLink Therapeutics (Suzhou) Co., Ltd.  to use MediLi...

January 13, 2025 | Monday | News
Global Proteomics Breakthrough: UK Biobank and Thermo Fisher to Decode Disease

UK Biobank Pharma Proteomics Project aims to create a comprehensive map of disease-associated protein levels in the human body to advance biomarker...

January 13, 2025 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close